By contrast, nonacademic PIs may see clinical trials more as a business opportunity-pharmaceutical contract research is profitable to US physicians because they get paid for every step of the trial process.
Pharmaceutical companies may now have more control over clinical trial data and more opportunities to suppress negative data through selective publication of study results than previously.